Insider · CIK 0001019231
University Of Texas/texas Am Investment Management Co
Files at RNTX (Aileron Therapeutics, Inc.), Silver Point Specialty Lending Fund. First filing May 1, 2024, latest May 29, 2026.
In brief
University Of Texas/texas Am Investment Management Co files SEC Form 4 as 10% owner at Silver Point Specialty Lending Fund, and also at RNTX (Aileron Therapeutics, Inc.). Since May 1, 2024, University Of Texas/texas Am Investment Management Co has reported 8 open-market buys worth $50M and 5 open-market sells worth $367k, the latest filed on May 29, 2026.
A track record needs three past buys with six months of prices behind them; University Of Texas/texas Am Investment Management Co has 0, so none is measured yet.
The newest scored trade: bought $1.3M of Silver Point Specialty Lending Fund on May 1, 2026, filed May 29, 2026, scored 37 (weak). In the last 12 months: 8 buys worth $50M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RNTX: Aileron Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | -buy Silver Point Specialty Lending Fund | $1.3M 47,481 shares | +1% | - | |
| 37Weak | -buy Silver Point Specialty Lending Fund | $2.4M 86,675 shares | +2% | - | |
| 37Weak | -buy Silver Point Specialty Lending Fund | $4.8M 170,984 shares | +4% | - | |
| 40Moderate | -buy Silver Point Specialty Lending Fund | $6.8M 245,231 shares | +7% | - | |
| 40Moderate | -buy Silver Point Specialty Lending Fund | $9.7M 347,237 shares | +10% | - | |
| 40Moderate | -buy Silver Point Specialty Lending Fund | $8.6M 609,116 shares | +10% | - | |
| 40Moderate | -buy Silver Point Specialty Lending Fund | $8.8M 622,252 shares | +11% | - | |
| 35Weak | -buy Silver Point Specialty Lending Fund | $7.6M 534,634 shares | +11% | - | |
| 12Weak | RNTXsell Aileron Therapeutics, Inc. | $22k 6,607 shares | -0% | +180% from low-54% from high | |
| 21Weak | RNTXsell Aileron Therapeutics, Inc. | $81k 24,671 shares | -1% | +177% from low-54% from high | |
| 18Weak | RNTXsell Aileron Therapeutics, Inc. | $41k 12,315 shares | -1% | +187% from low-52% from high | |
| 21Weak | RNTXsell Aileron Therapeutics, Inc. | $85k 20,315 shares | -1% | +262% from low-40% from high | |
| 23Weak | RNTXsell Aileron Therapeutics, Inc. | $139k 31,151 shares | -2% | +328% from low-29% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 29, 2024 | RNTX Aileron Therapeutics, Inc. | 723,984 4.29% of outstanding | $3.6M | Apr 29, 2024 | none |
Transactions
The newest 50 of 60 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | - Silver Point Specialty Lending Fund | POpen-market purchase COMMON SHARES | +47,481 | $27.36 | $1.3M | 4,283,064 | May 29, 2026 |
| Apr 1, 2026 | - Silver Point Specialty Lending Fund | POpen-market purchase COMMON SHARES | +86,675 | $27.47 | $2.4M | 4,235,582 | Apr 30, 2026 |
| Mar 2, 2026 | - Silver Point Specialty Lending Fund | POpen-market purchase COMMON SHARES | +170,984 | $27.85 | $4.8M | 4,148,908 | Apr 1, 2026 |
| Feb 2, 2026 | - Silver Point Specialty Lending Fund | POpen-market purchase COMMON SHARES | +245,231 | $27.93 | $6.8M | 3,977,924 | Mar 2, 2026 |
| Jan 2, 2026 | - Silver Point Specialty Lending Fund | POpen-market purchase COMMON SHARES | +347,237 | $27.96 | $9.7M | 3,732,692 | Feb 2, 2026 |
| Dec 1, 2025 | - Silver Point Specialty Lending Fund | POpen-market purchase COMMON SHARES | +609,116 | $14.12 | $8.6M | 6,770,911 | Dec 29, 2025 |
| Nov 1, 2025 | - Silver Point Specialty Lending Fund | POpen-market purchase COMMON SHARES | +622,252 | $14.18 | $8.8M | 6,161,795 | Nov 26, 2025 |
| Oct 1, 2025 | - Silver Point Specialty Lending Fund | POpen-market purchase Common Stock | +534,634 | $14.17 | $7.6M | 5,539,544 | Oct 27, 2025 |
| Jun 14, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -1,900 | $3.30 | $6,270 | 1,751,256 | Jun 17, 2024 |
| Jun 17, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -4,707 | $3.25 | $15k | 1,746,549 | Jun 17, 2024 |
| Jun 10, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -9,577 | $3.30 | $32k | 1,768,250 | Jun 12, 2024 |
| Jun 11, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -5,250 | $3.25 | $17k | 1,763,000 | Jun 12, 2024 |
| Jun 11, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -502 | $3.35 | $1,682 | 1,762,498 | Jun 12, 2024 |
| Jun 12, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -9,341 | $3.25 | $30k | 1,753,157 | Jun 12, 2024 |
| Jun 12, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -1 | $3.28 | $3 | 1,753,156 | Jun 12, 2024 |
| Jun 5, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -6,291 | $3.30 | $21k | 1,783,851 | Jun 7, 2024 |
| Jun 6, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -1,100 | $3.27 | $3,597 | 1,782,751 | Jun 7, 2024 |
| Jun 6, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -3,184 | $3.30 | $11k | 1,779,567 | Jun 7, 2024 |
| Jun 7, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -1,564 | $3.25 | $5,083 | 1,778,003 | Jun 7, 2024 |
| Jun 7, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -176 | $3.30 | $581 | 1,777,827 | Jun 7, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -3,100 | $4.10 | $13k | 1,807,357 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -100 | $4.11 | $411 | 1,807,257 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -1,750 | $4.12 | $7,210 | 1,805,507 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -380 | $4.13 | $1,569 | 1,805,127 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -1,600 | $4.15 | $6,632 | 1,803,527 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -670 | $4.15 | $2,781 | 1,802,857 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -400 | $4.18 | $1,672 | 1,802,457 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -7,923 | $4.25 | $34k | 1,794,534 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -310 | $4.26 | $1,321 | 1,794,224 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -317 | $4.27 | $1,352 | 1,793,907 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -100 | $4.27 | $427 | 1,793,807 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -200 | $4.28 | $855 | 1,793,607 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -337 | $4.28 | $1,442 | 1,793,270 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -200 | $4.29 | $857 | 1,793,070 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -2,903 | $4.29 | $12k | 1,790,167 | May 14, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -25 | $4.32 | $108 | 1,790,142 | May 14, 2024 |
| Apr 29, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -6,680 | $4.92 | $33k | 1,803,777 | May 1, 2024 |
| Apr 29, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -274 | $4.93 | $1,351 | 1,803,503 | May 1, 2024 |
| Apr 29, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -100 | $4.94 | $494 | 1,803,403 | May 1, 2024 |
| Apr 29, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -3,231 | $5.00 | $16k | 1,800,172 | May 1, 2024 |
| Apr 29, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -13 | $5.01 | $65 | 1,800,159 | May 1, 2024 |
| Apr 29, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -448 | $5.03 | $2,251 | 1,799,711 | May 1, 2024 |
| Apr 30, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -45 | $4.95 | $223 | 1,799,666 | May 1, 2024 |
| Apr 30, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -45 | $5.00 | $225 | 1,799,621 | May 1, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -3,100 | $4.10 | $13k | 1,796,521 | May 1, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -100 | $4.11 | $411 | 1,796,421 | May 1, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -1,750 | $4.12 | $7,210 | 1,794,671 | May 1, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -380 | $4.13 | $1,569 | 1,794,291 | May 1, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -1,600 | $4.15 | $6,632 | 1,792,691 | May 1, 2024 |
| May 1, 2024 | RNTX Aileron Therapeutics, Inc. | SOpen-market sale Common Stock | -670 | $4.15 | $2,781 | 1,792,021 | May 1, 2024 |
Questions about University Of Texas/texas Am Investment Management Co
Answered from the filings on this page, as of the latest one.
Is University Of Texas/texas Am Investment Management Co buying or selling?
In the last 12 months University Of Texas/texas Am Investment Management Co reported 8 open-market buys worth $50M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $1.3M of Silver Point Specialty Lending Fund on May 1, 2026. Grants, option exercises and tax withholding are not counted.
How did University Of Texas/texas Am Investment Management Co's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and University Of Texas/texas Am Investment Management Co has 0.
Where does University Of Texas/texas Am Investment Management Co file Form 4?
University Of Texas/texas Am Investment Management Co has filed Form 4 at Silver Point Specialty Lending Fund; RNTX (Aileron Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.